ALPS ADVISORS INC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$774,753
+38.4%
30,323
+55.3%
0.01%
+20.0%
Q2 2023$559,948
+160.4%
19,524
+34.8%
0.01%
+150.0%
Q3 2022$215,000
-13.0%
14,481
-7.6%
0.00%0.0%
Q2 2022$247,000
-66.2%
15,677
-42.2%
0.00%
-75.0%
Q1 2022$731,000
-35.3%
27,102
-11.2%
0.01%
-38.5%
Q4 2021$1,129,000
-26.7%
30,505
-5.4%
0.01%
-13.3%
Q3 2021$1,541,000
+31.4%
32,259
-6.9%
0.02%
+50.0%
Q2 2021$1,173,000
-12.1%
34,665
+11.5%
0.01%
-50.0%
Q3 2020$1,334,000
+2.1%
31,101
+11.3%
0.02%
+11.1%
Q2 2020$1,307,00027,9530.02%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders